Results 11 to 20 of about 4,347,639 (355)

Advances in mRNA-Based Cancer Vaccines

open access: yesVaccines, 2023
Cancer is a leading cause of death worldwide, accounting for millions of deaths every year. Immunotherapy is a groundbreaking approach for treating cancer through harnessing the power of the immune system to target and eliminate cancer cells.
Ling Ni
doaj   +2 more sources

Cancer Vaccines

open access: yesHematology/Oncology Clinics of North America, 2019
Cancer vaccines are a promising strategic approach within the rapidly growing field of immuno-oncology. Therapeutic cancer vaccines are distinct from prophylactic vaccines and vary by both target antigen and vaccine platform.
Bilusic, Marijo   +3 more
core   +3 more sources

Current status of clinical research on breast cancer vaccines

open access: yes结直肠肛门外科
Breast cancer vaccines mainly activate the patient’s own immune system to fight against breast cancer. With the continuous development of immunology, research on breast cancer vaccines has made significant progress, but they are still in the clinical ...
Chu Zhiliang   +4 more
doaj   +2 more sources

Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment [PDF]

open access: yes, 2021
In this editorial, we highlight articles published in this Special Issue of Vaccines on “Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment”, recent developments in the field of cancer vaccines, and the potential for immunotherapeutic ...
Jagmohan Singh   +5 more
core   +1 more source

Cancer vaccines

open access: yesCancer Cell, 2022
Given the renewed interest in vaccine development sparked by the COVID-19 pandemic, we are revisiting the current state of vaccine development for cancer prevention and treatment. Experts discuss different vaccine types, their antigens and modes of action, and where we stand on their clinical development, plus the challenges we need to overcome for ...
Schiller, John T   +13 more
openaire   +4 more sources

Targeting tumor heterogeneity with neoantigen-based cancer vaccines

open access: yes, 2023
Neoantigen-based cancer vaccines have emerged as a promising immunotherapeutic approach to treat cancer. Nevertheless, the high degree of heterogeneity in tumors poses a significant hurdle for developing a vaccine that targets the therapeutically ...
Chen, Shuxiong   +5 more
core   +1 more source

Vaccines Against Non-Infectious, Non-Cancer Novel Targets

open access: yes, 2015
This chapter discusses vaccines against non-infectious, non-cancer novel targets. It is part of a collection which takes a look at the current strategies, successes and challenges involved with the development of novel formulations of biologics, vaccines
Nimmo, Natalie   +7 more
core   +4 more sources

The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification.

open access: yes, 2021
Therapeutic cancer vaccines, an exciting development in cancer immunotherapy, share the goal of creating and amplifying tumor-specific T-cell responses, but significant obstacles still remain to their success.
Harrington, KJ   +9 more
core   +1 more source

Cancer vaccines [PDF]

open access: yesTrends in Pharmacological Sciences, 1993
1993 represents the 100th anniversary of William Coley's first report of tumor regressions induced by immune system activation in response to bacterial toxins. While many subsequent cancer vaccine trials have yielded tantalizing results, active immunotherapy has not yet become an established modality of cancer therapy.
openaire   +4 more sources

Cancer vaccines [PDF]

open access: yesPhilosophical Transactions of the Royal Society B: Biological Sciences, 2011
Abstract While vaccines are primarily thought of in terms of their use for prevention of infectious diseases, they can potentially be used to prevent or treat cancer. This manuscript explores the rationale for vaccines and immunotherapies for cancer from both the scientific and the global needs perspectives.
openaire   +4 more sources

Home - About - Disclaimer - Privacy